Literature DB >> 7150619

Cyanide-insensitive and clofibrate enhanced beta-oxidation of dodecanedioic acid in rat liver. An indication of peroxisomal beta-oxidation of N-dicarboxylic acids.

P B Mortensen, S Kølvraa, N Gregersen, K Rasmussen.   

Abstract

The beta-oxidation rate of dodecanedioic acid in rat liver homogenates (600 X g supernatant fraction) was determined by simultaneous measurements of the C6-C12-dicarboxylic acids, i.e., adipic, suberic, sebacic and dodecanedioic acids, in relation to time in assays incubated with dodecanedioic acid. Measurements were performed by a combined gas chromatographic-mass spectrometric technique, i.e., selected ion-monitoring. The beta-oxidation rate was registered as the consumption rate of dodecanedioic acid and as the initial rise in the concentrations of C6-C10-dicarboxylic acids. The beta-oxidation rate of C8-C12-dicarboxylic acids was increased many times in homogenates from clofibrate-treated rats. Moreover, it was unexpectedly found that 2.0 mM cyanide was unable to inhibit the beta-oxidation rate of the dicarboxylic acids in vitro, but in fact caused a minor increase in the rate of beta-oxidation in homogenates from both normal and clofibrate-treated rats. It was concluded that the present results strongly indicate the existence of a peroxisomal beta-oxidation of dicarboxylic acids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150619     DOI: 10.1016/0005-2760(82)90258-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Infantile Refsum disease: deficiency of catalase-containing particles (peroxisomes), alkyldihydroxyacetone phosphate synthase and peroxisomal beta-oxidation enzyme proteins.

Authors:  R J Wanders; R B Schutgens; G Schrakamp; H van den Bosch; J M Tager; A W Schram; T Hashimoto; B T Poll-Thé; J M Saudubrau
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

2.  Increased urinary excretion of dicarboxylic acids and 4-hydroxyphenyllactic acid in patients with Zellweger syndrome.

Authors:  E Mayatepek; C K Seppel; G F Hoffmann
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

3.  Implication of a peroxisomal enzyme in the catabolism of glutaryl-CoA.

Authors:  J Vamecq; F Van Hoof
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

4.  Comparison of the activities of some peroxisomal and extraperoxisomal lipid-metabolizing enzymes in liver and extrahepatic tissues of the rat.

Authors:  P Van Veldhoven; G P Mannaerts
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

5.  Hepatic peroxisomal and mitochondrial fatty acid oxidation in the riboflavin-deficient rat.

Authors:  P S Brady; C L Hoppel
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

6.  The microsomal dicarboxylyl-CoA synthetase.

Authors:  J Vamecq; E de Hoffmann; F Van Hoof
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

7.  Animal models for dicarboxylic aciduria.

Authors:  H S Sherratt; R K Veitch
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Fatty acyl-CoA dehydrogenase deficiency: enzyme measurement and studies on alternative metabolism.

Authors:  N Gregersen
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

9.  Rat liver peroxisomal and mitochondrial fatty acid oxidation in sepsis.

Authors:  T Yamamoto
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  A prenatal test for the cerebro-hepato-renal (Zellweger) syndrome by demonstration of the absence of catalase-containing particles (peroxisomes) in cultured amniotic fluid cells.

Authors:  R J Wanders; G Schrakamp; H van den Bosch; J M Tager; R B Schutgens
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.